8-K

Company

Centessa Pharmaceuticals plc

Filed

December 30, 2024

Period of Report

December 30, 2024

Accession Number

0001847903-24-000192

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →